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Background: Mice carrying the Ay allele at the agouti locus become obese and are heavier than their non-Ay
littermates. However, this does not hold true for the genetic background of the DDD mouse strain. At 22 weeks of
age, DDD.Cg-Ay females are heavier than DDD females, whereas DDD.Cg-Ay males are lighter than DDD males. This
study aimed to determine the possible cause and identify the genes responsible for the lower body weight of
DDD.Cg-Ay males.
Results: Growth curves of DDD.Cg-Ay mice were analyzed and compared with those of B6.Cg-Ay mice from 5 to 25
weeks. In DDD.Cg-Ay males, body weight gain stopped between 16 and 17 weeks and the body weight gradually
decreased; thus, the lower body weight was a consequence of body weight loss. Quantitative trait locus (QTL)
mapping was performed in backcrossed (BC) males of DDD × (B6 × DDD.Cg-Ay) F1-A
y mice. For the body weight at
25 weeks, significant QTLs were identified on chromosomes 1 and 4. The DDD allele was associated with a lower
body weight at both loci. In particular, the QTL on chromosome 4 interacted with the Ay allele. Furthermore,
suggestive QTLs for plasma glucose and high molecular weight adiponectin levels were coincidentally mapped to
chromosome 4. The DDD allele was associated with increased glucose and decreased adiponectin levels. When the
body weight at 25 weeks and plasma glucose levels were considered as dependent and independent variables,
respectively, BC Ay males were classified into two groups according to statistical analysis using the partition
method. Mice of one group had significantly higher glucose and lower adiponectin levels than those of the other
group and exhibited body weight loss as observed with DDD-Ay males.
Conclusions: The lower body weight of DDD.Cg-Ay male mice was a consequence of body weight loss. Diabetes
mellitus has been suggested to be a possible contributory factor causing body weight loss. The QTL on distal
chromosome 4 contained the major responsible genes. This QTL interacted with the Ay allele, implying the reason
why body weight loss occurs in DDD.Cg-Ay but not in DDD males.
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Traditionally, five single gene obesity mutations, Cpefat,
Tubtub, Lepob, Leprdb, and Ay, have been identified in
mice [1]. Among these, only the Ay allele is dominant and
homozygous lethal; therefore, living Ay mice are invariably
heterozygotes. Obesity in Ay mice is moderate and occurs
late compared with that in the other four mutants. Ay
mice also show metabolic abnormalities such as hypergly-
cemia and marked hyperinsulinemia, making them a suit-
able animal model system for studying obesity-associated
diabetes mellitus in humans.
In normal mice, the agouti gene is expressed only in the
skin [2,3], and it regulates pigmentation by acting as an in-
verse agonist of the melanocortin 1 receptor [4,5]. However,
in Ay mice, the Ay allele is associated with a large deletion,
which causes agouti gene expression to be aberrantly con-
trolled by the unrelated Raly gene promoter and results in
its ectopic overexpression [3,6-8]. Thus, Ay mice have a yel-
low coat color and develop maturity-onset obesity. Obesity
in Ay mice is thought to be a consequence of the agouti pro-
tein acting as a constitutive antagonist of the melanocortin 3
receptors (MC3R) and melanocortin 4 receptor (MC4R) by
mimicking the actions of the agouti-related protein [9-11].
Till date, two mouse strains congenic for the Ay allele
are available: B6.Cg-Ay (C57BL/6J background; hereafter
B6-Ay) and KK.Cg-Ay (KK/Ta background; hereafter KK-
Ay). We developed a third mouse strain congenic for the
Ay allele in an inbred DDD/Sgn (hereafter DDD) strain
background, (i.e., DDD.Cg-Ay; hereafter DDD-Ay) [12].
DDD-Ay females are significantly obese compared with
B6-Ay and KK-Ay females [13].Table 1 Designations of mouse strains used for growth analy
Designation Synonymous designation Strain background
DDDYM DDD-Ay male DDD
DDDYF DDD-Ay female DDD
DDDAM DDD male DDD
DDDAF DDD female DDD
B6YM B6-Ay male B6
B6YF B6-Ay female B6
B6AM B6 male B6
B6AF B6 female B6
DBYM DB-Ay male (♀DDD ×♂B6) F1
DBYF DB-Ay female (♀DDD ×♂B6) F1
DBAM DB male (♀DDD ×♂B6) F1
DBAF DB female (♀DDD ×♂B6) F1
BDYM BD-Ay male (♀B6 ×♂DDD) F1
BDYF BD-Ay male (♀B6 ×♂DDD) F1
BDAM BD male (♀B6 ×♂DDD) F1
BDAF BD female (♀B6 ×♂DDD) F1
Coat color of B6 males and B6 females is actually black but is classified as agouti (i.From our previous observations, DDD-Ay females (aver-
age body weight of 62.1 g at 22 weeks) are heavier than
DDD females (37.6 g), whereas DDD-Ay males (36.0 g) are
lighter than DDD males (40.4 g). Surprisingly, within a
DDD background, the Ay allele increased the female body
weight, whereas it reduced the male body weight. Within
B6 and KK backgrounds, Ay males are heavier than their
non-Ay male littermates.
To confirm this unusual phenomenon, we conducted
additional detailed analyses of the body weight and growth
in the DDD-Ay strain in comparison with those in B6-Ay
and reciprocal F1 strains. We also conducted some patho-
physiological analyses to determine possible causes of the
lower body weight. In addition, we conducted quantitative
trait locus (QTL) mapping analysis to identify genes asso-
ciated with the lower body weight within the DDD back-
ground based on the assumption that the lower body
weight was a heritable phenomenon.
Methods
Mouse strains
The inbred DDD mouse strain was maintained at the
National Institute of Agrobiological Sciences (NIAS,
Tsukuba, Ibaraki, Japan). The inbred B6 mouse strain
was purchased from Clea Japan, Inc. (Tokyo, Japan), and
the congenic B6-Ay mouse strain was purchased from
the Jackson Laboratory (Bar Harbor, ME, USA). The
congenic DDD-Ay mouse strain was established by intro-
gression of the Ay allele from the B6-Ay strain into the
DDD strain by backcrossing for 12 generations. Because
the original DDD strain had an albino coat, congenicses
Coat color (agouti genotype) Sex No. of mice used
Yellow (Ay) Male 14
Yellow (Ay) Female 23
Agouti (A) Male 17
Agouti (A) Female 14
Yellow (Ay) Male 11
Yellow (Ay) Female 17
Black (a) Male 11
Black (a) Female 15
Yellow (Ay) Male 9
Yellow (Ay) Female 10
Agouti (A) Male 9
Agouti (A) Female 10
Yellow (Ay) Male 12
Yellow (Ay) Female 16
Agouti (A) Male 22
Agouti (A) Female 15
e., A) for convenience.
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(Ay) and agouti (A) littermates to eliminate the Tyrc allele.
In this study, agouti littermates were used as DDD
control mice. Hereafter, DDD-Ay and B6-Ay are collect-
ively referred to as Ay mice. Likewise, their control litter-
mates, DDD and B6, were designated as non-Ay mice.
Mice homozygous for the Ay allele were embryonic le-
thal; thus, all Ay mice used in this study were heterozy-
gotes. Ay mice were distinguishable from non-Ay mice
because Ay mice had yellow coats (as opposed to non-Ay
mice with agouti or black coats).Table 2 Genetic markers used in this study and their map po
Marker Map positiona Marker Map position
Chromosome 1 Chromosome 6
D1Mit231 0 D6Mit116 0
D1Mit303 24.9 D6Mit224 17.3
D1Mit10 41.0 D6Mit188 27.1
D1Mit102 55.5 D6Mit39 38.9
D1Mit16 67.5 D6Mit108 44.4
D1Mit291 73.4 D6Mit256 45.3
D6Mit259 56.1
Chromosome 2
D2Mit312 0 Chromosome 7.1
D2Mit296 21.2 D7Mit250 0
D2Mit92 40.8
Chromosome 7.2
Chromosome 3 D7Mit362 0
D3Mit203 0
D3Mit25 19.7 Chromosome 8
D3Mit212 26.5 D8Mit191 0
D8Mit205 4.5
Chromosome 4 D8Mit249 13.6
D4Mit1 0 D8Mit183 28.4
D4Mit178 16.5
D4Mit166 27.8 Chromosome 9
D4Mit12 48.8 D9Mit59 0
D4Mit234 60.6 D9Mit191 13.5
D4Mit232 60.6 D9Mit207 19.9
D4Mit42 60.7 D9Mit198 42.2
D9Mit212 55.5
Chromosome 5
D5Mit267 0 Chromosome 10
D5Mit113 16.6 D10Mit188 0
D5Mit239 23.0 D10Mit183 3.1
D5Mit161 34.7 D10Mit42 29.0
D5Mit221 52.6 D10Mit95 33.3
aMap positions (cM) were based on a linkage map calculated using 196 BC males.We also analyzed reciprocal F1 mice produced by a
cross between DDD (−Ay) and B6 (−Ay) strains.
(♀DDD ×♂B6-Ay) F1 mice were designated DB, and
(♀B6 ×♂DDD-Ay) F1 were designated BD. Following the
designations of inbred strains, DB-Ay and BD-Ay mice
were referred to as Ay mice and their agouti littermates
were referred to as non-Ay mice. The mouse strain des-
ignations used in this study are summarized in Table 1.
Mice were weaned at 4 weeks of age, and 4–5 mice were
housed together during the experimental period. All the
mice were maintained in a specific pathogen-free facilitysitions
Marker Map position Marker Map position
Chromosome 11 Chromosome 16
D11Mit236 0 D16Mit131 0
D11Mit36 45.9 D16Mit57 6.8
D11Mit124 51.4 D16Mit136 25.8
D11Mit61 65.6 D16Mit139 38.8
D16Mit49 44.4
Chromosome 12
D12Mit136 0 Chromosome 17
D12Mit172 6.9 D17Mit164 0
D12Mit156 20.7 D17Mit176 9.4
D12Mit259 26.5 D17Mit139 13.5
D12Mit141 47.3 D17Mit93 41.1
D12Nds2 49.3 D17Mit123 60.3
Chromosome 13 Chromosome 18
D13Mit207 0 D18Mit21 0
D13Mit64 16.1 D18Mit149 12.0
D13Mit110 46.1 D18Mit152 22.0
D13Mit213 53.0 D18Mit25 71.1
D13Mit171 56.3
Chromosome 19
Chromosome 14 D19Mit32 0
D14Mit64 0 D19Mit91 34.3
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humidity. Food (CRF-1; Oriental yeast Co. Ltd., Tokyo,
Japan) and water were freely available throughout the ex-
perimental period. All the animal experiments were
conducted in accordance with the guidelines of the Insti-
tutional Animal Care and Use Committee of NIAS.
Body weight measurements and growth analysis
Body weights were weekly measured from 5 to 25 weeks
of age and were determined to the nearest 0.01 g using
an electronic balance. The average body weights of mice
from 5 to 25 weeks were modeled as the study outcomes
using the following three equations:
Bodyweight ¼ a 1−e−bWeek þ ε ð1Þ
Log Bodyweightð Þ ¼ aþ b Log Weekð Þ þ ε ð2Þ
Log Bodyweightð Þ ¼ aþ b Log Weekð Þ þ c
 Log Weekð Þ½ 2 þ ε ð3ÞFigure 1 Comparison of growth curves among group-housed inbred
weights were determined from 5 to 25 weeks of age. Each point represent
indicated by error bars.Eqs. 1 and 2 are known as the von Bertalanffy growth
model [14] and the elasticity model [15], respectively. In
Eq. 1, the body weight at birth was assumed to be zero
and the growth rate was considered to be proportional to
the maximum size minus the current size. Thus, the body
weight reached an upper limit value over time. In Eq. 2,
elasticity was a coefficient estimated from a linear regres-
sion equation where both dependent and independent var-
iables were presented as natural logs. In this model, the
growth rate was proportional to the current ratio of the
body weight to age. In Eq. 3, we added a quadratic term to
Eq. 2 to fit the curves better to the observed data. In Eqs. 2
and 3, the body weight was expressed as Exp (a) at 1 week
of age using the value of parameter a.
For these analyses, the independent variable of time
was treated as a continuous variable and mouse charac-
teristics (strain, agouti, sex, and their interactions) were
treated as nominal variables.
For the agouti genotype (i.e., whether the mouse had
the Ay allele), mice with or without the Ay allele weremales (A) and females (B) and F1 males (C) and females (D). Body
s the average body weight of each strain, and standard errors are
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males and females were designated M and F, respect-
ively. With regard to strains, mice were classified into
one of the following four strains: DDD, B6, BD, and DB.
Agouti, sex, and strain were used as independent vari-
ables and designated Strain*Agouti*Sex. All the mice
were classified into one of the following 16 categories:
DDDYM, DDDYF, DDDAM, DDDAF, B6YM, B6YF,
B6AM, B6AF, DBYM, DBYF, DBAM, DBAF, BDYM,
BDYF, BDAM, and BDAF.
In this study, growth models were designated models 1,
2, and 3, as described by Eqs. 1, 2, and 3, respectively. Each
of the 16 Strain*Agouti*Sex categories was analyzed using
the three models. In model 1, the maximum likelihood es-
timates for parameter values were obtained by minimizing
the deviance in the observed data by weighting by the
number of mice. The 95% confidence intervals (CIs) were
determined using the profile likelihood. In models 2 and
3, the optimum estimates and 95% CI for the parameters
were determined using the least-squares method weighted
by the number of mice. Statistical significance was set at
the α = 0.05 level. Data analysis used JMP ver. 9.0.1 statis-
tical software (SAS Institute Inc., Cary, NC, USA).
Blood phenotype analyses
At 25 weeks of age, mice were euthanized with an over-
dose of ether after they were fasted for 4 h. Whole blood
was drawn from the heart into a plastic tube using heparinTable 3 Summary of growth models for mice categorized wit
Model 1 Model 2
Values of parameters Values of paramet
Individual variable Category a b Residuals a b Res
aB6AF 24.8 0.235 1.912 2.621 0.197 0.0
aB6AM 33.3 0.200 1.938 2.751 0.249 0.1
aB6YF 52.2 0.089 0.960 2.176 0.532 0.2
aB6YM 50.9 0.118 0.476 2.509 0.443 0.2
bBDAF 31.0 0.170 1.277 2.530 0.291 0.0
bBDAM 38.6 0.180 1.537 2.805 0.276 0.0
Strain*Agouti*Sex aBDYF 65.2 0.076 0.801 2.177 0.584 0.1
aBDYM 55.3 0.131 0.655 2.742 0.400 0.2
bDBAF 32.7 0.179 1.323 2.654 0.270 0.0
bDBAM 42.8 0.174 1.386 2.882 0.282 0.0
bDBYF 68.0 0.081 1.329 2.387 0.536 0.0
aDBYM 60.0 0.151 0.770 2.998 0.352 0.2
aDDDAF 39.7 0.137 1.217 2.523 0.364 0.0
bDDDAM 46.9 0.160 1.600 2.875 0.312 0.0
aDDDYF 72.3 0.094 1.165 2.523 0.534 0.6
aDDDYM 43.4 0.292 2.044 3.375 0.133 0.5
aModel 3 best fits the observed data.
bModel 2 best fits the observed data.as an anticoagulant. Blood glucose (BGLC) levels were
then determined using Glutest Pro R (Sanwa Kagaku
Kenkyusho, Aichi, Japan) according to the manufacturer’s
instructions. Sample tubes were centrifuged at 7,000 rpm
for 5 min at 4°C to separate plasma. The plasma samples
were maintained at −70°C until use. Plasma glucose
(PGLC) levels were determined using a clinical colorimet-
ric kit (Glucose C-II Test Wako, Wako Pure Chemical In-
dustries, Osaka, Japan). Plasma total-cholesterol (CHO)
and triglyceride (TG) levels were determined using Chol-
esterol E Test Wako and Triglyceride E Test Wako (Wako
Pure Chemical Industries). Plasma high-molecular-weight
adiponectin (HMW adiponectin) levels were determined
using the Mouse/Rat High Molecular Weight Adiponectin
ELISA Kit (AKMAN-011, Shibayagi, Gunma, Japan).
For statistical comparisons between groups, the Tukey–
Kramer honestly significant difference (HSD) test was used.
P values <0.05 were considered statistically significant.
Histology
The liver, pancreas, and adipose tissues were removed at
necropsy from parental strains of both the sexes.
Formalin-fixed tissues were embedded in paraffin, sec-
tioned, and stained with hematoxylin and eosin.
Other phenotyping
The anal–nasal length of each mouse was measured
using a pair of digital calipers to the nearest 0.01 mmh respect to individual variables of strain*agouti*sex
Model 3
ers Values of parameters
iduals Adjusted R2 a b c Residuals Adjusted R2
80 0.969 2.248 0.511 −0.063368 0.025 0.990
24 0.959 2.176 0.732 −0.097586 0.029 0.990
21 0.989 1.578 1.035 −0.101656 0.062 0.997
56 0.973 1.593 1.212 −0.155501 0.016 0.998
02 0.993 2.555 0.270 0.004 0.002 0.993
61 0.992 2.686 0.376 −0.020256 0.053 0.992
43 0.994 1.623 1.050 −0.094138 0.015 0.999
08 0.975 1.973 1.047 −0.130541 0.023 0.997
46 0.985 2.975 0.000 0.054 0.020 0.993
29 0.991 2.943 0.232 0.010 0.028 0.990
62 0.995 2.366 0.554 −0.003482 0.062 0.995
03 0.959 2.119 1.090 −0.14911 0.022 0.995
24 0.997 2.407 0.462 −0.019735 0.019 0.998
42 0.994 2.800 0.375 −0.012714 0.040 0.994
91 0.976 1.453 1.433 −0.1816 0.000 1.000
17 0.670 2.226 1.098 −0.194955 0.035 0.976
Figure 2 Growth curves of DDDYF and DDDYM mice based on
Model 1 (A) and Model 3 (B). Lines indicate predicted values and
markers indicate observed data.
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length was defined as the anal–nasal length. Body mass
index (BMI) was calculated as follows: body weight
(g)/[body length (mm)]2 × 103. BMI was used to esti-
mate the degree of obesity.
QTL mapping
QTL mapping analysis was conducted to identify genes
possibly associated with the lower body weight of
DDD-Ay males. We produced 196 backcross (BC)
males, comprising 100 Ay (BC Ay) and 96 non-Ay (BC
non-Ay) males, from a genetic cross of ♀DDD×♂(♀B6 ×
♂DDD-Ay) F1-A
y mice. This backcrossing was chosen
because neither BD-Ay males nor DB-Ay males showed
body weight loss and the DDD alleles involved in this
phenomenon were considered to be recessive to the B6
allele. QTL analysis was primarily conducted in 100 BC
Ay males; 96 BC non-Ay males were genotyped for all
markers on chromosomes 1 and 4.
Genomic DNA isolation and genotyping of microsatel-
lite markers used the procedures described in our previous
study [13]. Microsatellite markers used in this study are
listed in Table 2 with their map positions (cM) calculated
using 196 BC males. X chromosome-linked markers were
not genotyped because they were not informative with this
genetic cross.
Notably, chromosome 7 is divided into two parts. Because
of the introgression of the Tyr locus from the B6 strain, an
intermediate part of the DDD genome on chromosome 7 is
replaced by a B6 genome in DDD-Ay mice. In this study, a
region proximal to the B6 region was defined as “chromo-
some 7.1 (D7Mit250)” whereas a region distal to the B6 re-
gion was defined as “chromosome 7.2 (D7Mit362).”
QTL analysis was conducted using R/qtl [16,17].
Threshold logarithm of odds (LOD) scores for suggestive
(P < 0.63) and significant (P < 0.05) linkages were deter-
mined by performing 1,000 permutations for each trait
[18]. For significant QTLs, 95% CI was defined by a de-
cline of 1.5 LOD. After single QTL scans, pairwise eval-
uations for potential interactions between loci were
made. At this stage, threshold LOD scores were strictly
based on those recommended by Broman and Sen [16].
To determine whether the effect of QTL was specific-
ally identified in the presence of the Ay allele, data for
BC Ay and BC non-Ay mice were combined and
reanalyzed using the agouti locus genotype as a covari-
ate. Because the difference between the LOD score with
the agouti locus genotype as an interactive covariate and
the LOD score with the agouti locus genotype as an
additive covariate concerns the test of the QTL × agouti
locus genotype interaction, this test was performed for
combined BC mice.
After QTL mapping, we genotyped interferon acti-
vated gene 202B (Ifi202b) and zinc finger protein 69(Zfp69) to test their suitability as candidate genes for the
QTLs.
Statistical analysis using a linear model and partition
method
Body weights of BC Ay males at 25 weeks of age were
used as the dependent variable in the linear model and
partition method with JMP ver. 9.0.1 statistical software.
PGLC, CHO, TG, and HMW adiponectin levels were in-
dependent variables and treated as continuous variables.
The best-fit linear model was generated from a full model
by reducing nonsignificant terms using stepwise proce-
dures. In the partition method, PGLC levels were used as
an independent variable. We stopped first or second splits
because of the small sample size. The clusters split in the
partition method were treated as independent nominal
variables. Comparisons of the associations between the
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at 25 weeks, BMI, PGLC, CHO, TG, and HMW
adiponectin levels) were made by an F-test, followed by
Student’s or Welch’s test. P values <0.05 was considered
statistically significant. The average body weights of BC Ay
males clustered in the partition method were modeled
from 5 to 25 weeks of age using model 3 described by
Eq. 3.Figure 3 Comparison of blood phenotypes at 25 weeks of age after 4
levels, (B) plasma triglyceride levels, (C) plasma total-cholesterol levels, and
The sample sizes of mice for glucose, triglyceride, and total-cholesterol det
were determined in 7–10 mice for each strain. Males and females were ana
however, the results of statistical comparisons are shown only for those rel
DDD, B6-Ay, B6, (DDD × B6) F1, (B6 × DDD) F1-A
y, and (B6 × DDD) F1. NS, no
Significant difference (P <0.0001) versus B6-Ay, B6, (DDD × B6) F1, (B6 × DDD
DDD. NS, no significant difference between DDD-Ay and (DDD × B6) F1-A
y.
difference (P <0.0001) versus B6-Ay, and significant difference (P <0.05) versResults
Growth of DDDYM mice stops between 16 and 17 weeks,
following which body weight gradually declines
Figure 1 shows the growth curves of the parental inbred
mouse strains (A, males; B, females) and F1 mice (C, males;
D, females) from 5 to 25 weeks of age. The corresponding
growth curve analytic results are shown in Table 3. Growth
curve data were best fit to model 3 for 10 of 16 mouseh of fasting in parental and F1 mouse strains. (A) Blood glucose
(D) plasma HMW adiponectin levels. Error bars indicate standard errors.
ermination was the same as those in Table 1. HMW adiponectin levels
lyzed separately. All pairs were compared by Tukey–Kramer HSD tests;
ated to DDD-Ay males. A, Significant difference (P <0.0001) versus
significant difference between DDD-Ay and (DDD × B6) F1-A
y. B,
) F1-A
y, and (B6 × DDD) F1, and significant difference (P <0.002) versus
C, Significant difference (P <0.01) versus DDD and B6-Ay. D, Significant
us DDD and B6.
Table 4 Phenotypes of BC males





Body weight (g) 43.64 ± 0.59 49.37 ± 0.51
(33.05–57.90) (36.13–60.28)
BMI 4.00 ± 0.04 4.48 ± 0.04
(3.22–4.94) (3.61–5.31)
Blood glucose (mg/dl) a 209.1 ± 4.4 329.7 ± 14.9
(115–379) (110–600)
Plasma glucose (mg/dl) nd 427.3 ± 18.6
(164–869)
Total-cholesterol (mg/dl) 121.7 ± 2.7 154.0 ± 4.4
(69–198) (74–303)
Triglyceride (mg/dl) 245.2 ± 9.9 622.0 ± 24.7
(98–778) (109–1,247)
HMW adiponectin (μg/ml) nd 3.81 ± 0.13
(1.67–9.15)
aSeven mice had blood glucose levels that exceeded the upper limit of the
measuring method (600 mg/dl). Therefore, mean ± SE values were calculated
by assuming that their blood glucose levels were 600 mg/dl.
Values are significantly greater in BC Ay than in BC non-Ay males. nd,
not determined.
Table 5 Summary of single QTL scans in BC-Ay mice
Trait Chromosome Location (cM)a 9




BMI 1 56 0
4 55 3
6 45 0
Blood glucose 4 61 2
7.1 0 n
12 30 0




Plasma triglyceride 8 14 0
12 27 7
18 0 0
HMW adiponectin 4 39 1
7.1 0 n
aLocation indicates a chromosomal position showing a peak LOD score in cM.
b95% CI is defined by a 1.5-LOD support interval. na, not available.
cMaximum LOD score for QTL. Significant QTLs are indicated by * (suggestive QTLs
dAllele associated with higher trait values.
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DBYM, DDDAF, DDDYF, and DDDYM. Growth curve
data were best fit to model 2 for the remaining six categor-
ies: BDAF, BDAM, DBAF, DBAM, DBYF, and DDDAM.
The fits of the observed data to all the three models were
statistically significant (P < 0.05).
In model 1, the maximum body weight ranged from
24.8 g (B6AF mice) to 72.3 g (DDDYF mice). In non-Ay
mice, the maximum body weight of males was greater
than that of females within the same strain. In contrast,
in Ay mice, the maximum body weight of females was
greater than that of males within the same strain. The
growth rate was the greatest in DDDYM mice (0.292).
The body weight of DDDYM mice reached the max-
imum value at the earliest age. The difference in the
maximum body weight between males and females was
the greatest in DDDY mice (28.9 g) (Figure 2A).
In accordance with the results with model 1, the
growth rate was the lowest in DDDYM mice (0.133) in
model 2. The adjusted R-squared value was the smallest
in DDDYM mice (0.670). The adjusted R-squared values
for the other categories were >0.900.
In model 3, DDDYM mice reached their maximum body
weights (mean = 43.5 g) at 16.7 weeks of age (Figure 2B).
The maximum body weight of DDDYM mice was nearly
equal to that obtained in model 1 (mean = 43.4 g). The5% CI (cM)b Max LODc Nearest marker High alleled
5–73 2.69* D1Mit102 B6
1–61 4.25* D4Mit234 B6
–56 1.44 D6Mit108 B6
–80 1.39 D15Mit193 DDD
–73 1.48 D1Mit102 B6
6–61 4.77* D4Mit234 B6
–56 2.16 D6Mit256 B6
1–61 1.88 D4Mit234 DDD
a 1.54 D7Mit250 B6
–49 1.82 D12Mit259 B6
3–65 1.55 D4Mit234 DDD
a 1.56 D7Mit250 B6
0–49 2.28 D12Mit259 B6
–35 1.73 D19Mit32 DDD
–28 1.77 D8Mit249 DDD
–44 2.39 D12Mit259 DDD
–71 1.42 D18Mit21 DDD
0–61 1.89 D4Mit12 B6
a 1.57 D7Mit250 DDD
are shown without asterisks).
Figure 4 Genome-wide LOD score plots for body weights at 25 weeks of age (blue lines) and BMI (green lines). Horizontal dashed lines
indicate significant and suggestive threshold LOD scores determined by 1,000 permutations.
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http://www.biomedcentral.com/1471-2156/14/35body weights of the other mouse categories did not reach
the maximum values during the observation period. The
values for the parameter c were positive in BDAF, DBAF,
and DBAM mice, but were negative in the remaining 13
categories. The smallest value for the parameter c was
found in DDDYM mice (−0.195).
Blood phenotypes of DDD-Ay males
We determined the BGLC, CHO, TG, and HMW
adiponectin levels in parental strains at 25 weeks of age.
The first three levels were also determined for F1 mice.
DDD-Ay and DB F1-A
y males had significantly higher
BGLC levels than mice with other genotypes. NoFigure 5 Changes in LOD scores for QTLs on chromosomes 1 and 4 frsignificant differences in BGLC levels were observed be-
tween DDD-Ay and DB F1-A
y males (Figure 3A). DDD-
Ay and DDD mice clearly had higher TG levels than
B6-Ay and B6 mice for both the sexes (Figure 3B). In
particular, DDD-Ay males had significantly higher TG
levels than the other strains, except for DB F1-A
y males.
In contrast, DDD-Ay and DDD mice were not hypercho-
lesterolemic compared with B6-Ay and B6 mice, respect-
ively, for both the sexes (Figure 3C). Conversely, DDD-Ay
males had significantly lower CHO levels than DDD and
B6-Ay males. DDD-Ay males had significantly lower HMW
adiponectin levels than B6-Ay, B6, and DDD males
(Figure 3D).om 5 to 25 weeks of age.
Figure 6 Allele effects of QTLs on chromosomes 1 (A) and 4 (B) on body weight at 25 weeks of age. The DDD allele was associated with
lower body weight at both loci in BC Ay mice. In particular, the allele effect of the QTL differed between BC Ay and BC non-Ay mice.
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No marked abnormalities were observed in the pancreas
and adipose tissues of any of the mice. Liver lesions were
observed only in Ay mice, although these were found in
both the sexes. Indeed, fatty changes were observed in
DDD-Ay and B6-Ay males, while glycogen deposition
was observed in DDD-Ay and B6-Ay females. Deposition
of large fat droplets was observed in DDD-Ay and B6-Ay
females (data not shown).
QTLs associated with lower body weight of DDD.Cg-Ay
males are identified on chromosomes 1 and 4
We conducted QTL analyses for body weight (from 5 to
25 weeks of age), BMI, and BGLC, PGLC, CHO, TG,
and HMW adiponectin levels using the results of 100
BC Ay males. Seven BC Ay males had BGLC levels
of >600 mg/dl, the upper limit of detection for the
method used. Their BGLC levels were assumed to be
600 mg/dl. To make glucose determination more exact,Figure 7 Genome-wide LOD score plots for plasma HMW adiponectin le
glucose levels (dashed green lines). A horizontal dashed line indicates a swe also measured PGLC levels; PGLC levels were highly
correlated with BGLC levels (r = 0.95; P <0.0001). Phe-
notypes are shown in Table 4 along with those for 96 BC
non-Ay males. Phenotypic values were significantly
greater in BC Ay males than in BC non-Ay males (PGLC
and HMW adiponectin levels were not determined in
BC non-Ay males).
The results of single QTL scans are summarized in
Table 5. For the body weight at 25 weeks of age, two sig-
nificant QTLs were identified on chromosomes 1 and 4
(Figure 4). For 21 QTL analyses of body weight
conducted weekly (from 5 to 25 weeks), significant
QTLs were identified only on chromosomes 1 and 4.
QTL results for chromosome 1 were significant only for
body weight at 25 weeks of age (Figure 5). In contrast,
QTL results for chromosome 4 were significant from 14
weeks onward, except at 16 weeks. For both QTLs, the
DDD allele was associated with a lower body weight
(Figure 6).vels (blue lines), blood glucose levels (solid green lines), and plasma
uggestive threshold LOD score determined by 1,000 permutations.
Figure 8 Allele effects of a QTL on chromosome 4 on (A) plasma glucose and (B) plasma HMW adiponectin levels in BC Ay mice. The
DDD allele was associated with increased plasma glucose levels and decreased HMW adiponectin levels.
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http://www.biomedcentral.com/1471-2156/14/35For BMI, one significant QTL was identified on
chromosome 4 (Figure 4). For this QTL, the DDD allele
was associated with lower BMI. Suggestive QTLs for
HMW adiponectin, BGLC, and PGLC levels were
colocalized with the QTL for body weight on chromosome
4 but not with the QTL on chromosome 1 (Figure 7). The
DDD allele was associated with increased BGLC and
PGLC levels and decreased HMW adiponectin levels
(Figure 8). For BGLC and PGLC, suggestive QTLs were
also identified on chromosomes 7.1 and 12. At both loci,
the B6 allele was associated with increased glucose levels.
Three suggestive QTLs were identified for TG levels on
chromosomes 8, 12, and 18 (Figure 9). The suggestive
QTL on chromosome 12 coincided with the suggestive
QTLs for BGLC and PGLC levels. The DDD allele was as-
sociated with increased TG levels. No significant or sug-
gestive QTLs were identified for CHO levels. The effects
of the loci on chromosomes 1 and 4 for TG and CHO
levels were negligible.Figure 9 Genome-wide LOD score plots for plasma triglyceride (blue
line indicates a suggestive threshold LOD score determined by 1,000 permWe next addressed whether the effects of QTLs on
chromosomes 1 and 4 could be identified in the absence
of the Ay allele (i.e., in BC non-Ay males), i.e., whether or
not QTLs on chromosomes 1 and 4 interacted with the
Ay allele. When QTL analysis of body weight at 25
weeks of age was conducted for 96 BC non-Ay males,
there was no evidence of linkage with regard to chromo-
somes 1 and 4 (Figure 10). When BC Ay and BC non-Ay
males were combined and reanalyzed using the agouti
locus genotype (Ay or non-Ay) as a covariate, significant
evidence of a QTL × covariate interaction was identified
for the QTL on chromosome 4 but not for the QTL on
chromosome 1 (Table 6 and Figure 11). Thus, the effect
of the QTL on chromosome 4 differed between in BC
Ay and in BC non-Ay males, i.e., the effect of this QTL
differed between in the presence and absence of the Ay
allele (Figure 6B).
We further mapped these QTLs using a reference map
position retrieved from Mouse Genome Informatics (MGI,lines) and total-cholesterol (green lines) levels. A horizontal dashed
utations.
Figure 10 LOD scores for QTLs on chromosomes 1 and 4 for
body weight at 25 weeks of age in BC Ay (blue lines) and BC
non-Ay males (red lines). QTL peak is indicated by an arrow. The
nearest markers are also shown.
Figure 11 Evidence for and the chromosomal location of a QTL
that interacts with the Ay allele on chromosome 4. Nearest
marker for the QTL peak is indicated by an arrow.
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http://www.biomedcentral.com/1471-2156/14/35http://www.informatics.jax.org/) in order to search possible
candidate genes for the QTLs. For this purpose, we ex-
cluded genotype data on D1Mit16 and D4Mit234 because
information on Mbp position was not available for these
markers. Instead, we newly genotyped D1Mit36 (169.21
Mbp), D1Mit356 (172.89 Mbp), D1Mit155 (194.43 Mbp),
and D4Mit204 (133.43 Mbp). Results of single QTL scans
for body weight at 25 weeks are summarized in Table 7.
The 95% CI for QTLs on chromosomes 1 and 4 contained
plausible candidate genes, Ifi202b and Zfp69, respectively,
both of which were known to be related with obesity-
associated diabetes [19,20].
Therefore, we genotyped Ifi202b and Zfp69 to test
their suitability as candidate genes for the QTLs. For the
genotyping of Ifi202b, we performed two kinds of PCR
using cDNA as a template [19]. As shown in Figure 12A
and Table 8, forward primer corresponding to the corre-
sponding to the exon 1B (F1), which was missing in B6, inTable 6 Single QTL scans for body weight at 25 weeks
in combined BC mice using the agouti genotype as a
covariate












4 None 3.52 (61) 2.27 (49)
Only significant QTLs are listed.
aSignificant threshold LOD score was 2.57.
bSignificant threshold LOD score was 3.28.
cLODi is the difference between the LOD score with agouti as an interactive
covariate (LODf) and the LOD score with agouti as an additive covariate
(LODa). This derives from a test of the QTL × agouti interaction. Significant
threshold LOD score was 1.91.combination with reverse primers on exon 3 (R1) and
2 (R2) amplified a PCR product only on DDD cDNA
(Figure 12B and Figure 12C, respectively). For the geno-
typing of Zfp69, we performed PCR using cDNA as a tem-
plate [20]. As shown in Figure 13A and Table 8, forward
primer corresponding to the exon 3 (F2) in combination
with reverse primer on B6-specific exon 3A (R3) amplified
a PCR products on B6 and DDD (Figure 13B). We also
performed PCR using unrelated RR/Sgn strain but it did
not generate a PCR product.
Statistical analysis with a linear model and partition method
The best-fit linear model was as follows:
Body weight ¼ aþ b PGLC levelsð Þ þ c
 HMW adiponectin levelsð Þ þ d
 PGLC levelsð Þ2 þ ε ð4Þ
In Eq. 4, PGLC and HMW adiponectin levels were
linearly related to the body weight and the square of PGLC
levels was related to the body weight. Estimates for the four
parameters were as follows: a = 32.4, b =0.068, c = 1.06,
and d = −7.5×10−5. The adjusted R-squared value and theTable 7 Mapping of QTLs on chromosomes 1 and 4 for
body weight at 25 weeks using reference map position
Chromosome Location
(Mbp)a




1 147.25 106.49–188.44 2.69 Ifi202b (173.96)
4 145.06 112.44–151.57 4.25 Zfp69 (120.93)
aLocation indicates a chromosomal position showing a peak LOD score
in Mbp.
b95% CI is defined by a 1.5-LOD support interval in Mbp.
cMaximum LOD score for QTL.
Figure 12 Genotyping of Ifi202b in B6 and DDD mice. (A) Genomic organization and PCR primers used for genotyping of Ifi202b on chromosome 1
based on reference [19]. (B, C) Identification of the cDNA variants in B6 and DDD by PCR. 100 bp ladder markers are shown in the left.
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http://www.biomedcentral.com/1471-2156/14/35root mean square error were 0.255 and 4.37 g, respectively.
Body weight at 25 weeks of age increased in direct propor-
tion to HMW adiponectin levels. Figure 14A shows the as-
sociation between the observed body weights at 25 weeks
of age and the predicted body weights from Eq. 4. The pre-
dicted body weight reached a maximum (51.9 g) at the
point when the PGLC level was 427.3 mg/dl.
When the body weight at 25 weeks of age was used as
the dependent variable, BC Ay males were categorized
into two groups with the first split of the partition
method. The first group included nine mice with PGLC
levels ≥715 mg/dl, and the second group included 91
mice with PGLC levels <715 mg/dl. The average body
weight of the first group was 41.2 g and that of the sec-
ond group was 50.2 g. We defined the first group as “ab-
normal mice” and the second group as “normal mice.”
Abnormal mice were characterized by higher PGLC
levels and lower HMW adiponectin levels compared
with normal mice.
In Figure 14A, the nine abnormal mice were mapped to
the lower right of the plot area, in which mice had PGLC
levels ≥715 mg/dl and body weights ranging from 37.4 g
to 43.8 g. Comparisons of the phenotypes between these
two groups are summarized in Table 9. Body weight, BMI,Table 8 A list of primers used for genotyping of
candidate genes
Primer namea Primer sequence (5’-to-3’)
F1 CCC TCT TCC TTT ACA CCC AAC
F2 CCA TGA TGC TAA TGG GAC AC
R1 TTG GGG TGT GTG ACT TTT TG
R2 GCC TGG GAC AGA TGT CTC TT
R3 TCT ACG GCA AAG CTT TAT TGC
aPrimer name beginning with “F” means that the primer was used as a
forward primer, and that beginning with “R” means that the primer was used
as a reverse primer.BGLC levels, PGLC levels, and HMW adiponectin levels
significantly differed between these abnormal and normal
mice. In contrast, CHO and TG levels did not differ sig-
nificantly between these two groups.
Figure 14B shows a comparison of the growth curves
of abnormal and normal mice using model 3. For abnor-
mal mice, estimates for the three parameters in this
model were a = 1.33, b = 1.82, and c = −0.34. For nor-
mal mice, these estimates were a = 1.45, b = 1.56, and
c = −0.25. The adjusted R-squared value and the root
mean square errors were 0.99 and 0.016, respectively.
The average body weight of abnormal mice was greater
than that of normal mice until 10.7 weeks. Following
this, body weight trends reversed between these two
groups; normal mice became heavier than abnormal
mice. Abnormal mice reached their maximum body
weight (45.2 g) at 15.1 weeks of age, following which
their body weight declined.
Discussion
Growth of DDDYM mice was peculiar among the 16
categories, and the lower body weight of the DDDYM
mice was a consequence of body weight loss
From the results of model 1, the maximum body weight
of males was greater than that of females of the same
strain in non-Ay mice (Table 3). The maximum body
weight of 46.9 g in DDDAM mice was greater than that
of 39.7 g in DDDAF mice. In contrast, the maximum
body weight of females was greater than that of males of
the same strain in Ay mice. The maximum body weight
of 72.3 g in DDDYF mice was greater than that of 43.4 g
in DDDYM mice. The greatest maximum body weight
of non-Ay mice was lesser than the smallest maximum
body weight of Ay mice, which indicated that the Ay
allele had a strong effect on growth irrespective of strain
or sex.
Figure 13 Genotyping of Zfp69 in B6 and DDD mice. (A) Genomic organization and PCR primers used for genotyping of Zfp69 on chromosome 4
based on reference [20]. (B) Identification of the cDNA variants in B6, DDD, and unrelated RR by PCR. 100 bp ladder markers are shown in the left.
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http://www.biomedcentral.com/1471-2156/14/35Because the maximum body weight of 50.9 g in B6YM
mice was greater than that of 33.3 g in B6AM mice, the
maximum body weight of DDDYM mice should have
been greater than that of DDDAM mice. However, the
maximum body weight of DDDYM mice was lesser than
that of DDDAM mice. In model 3, the growth of
DDDYM mice stopped between 16 and 17 weeks, fol-
lowing which their body weight declined. In contrast,
the body weight of DDDYF mice continued to increase
during the observation period (Figure 2B).
Based on these results, we concluded that the growth
of DDDYM mice was quite peculiar among the 16 cat-
egories of mice used in this study. This peculiar growth
was supported by the following evidence: (1) among the
16 categories of mice, the growth rate was the greatest
using model 1; (2) the adjusted R-squared value was the
smallest using model 2; and (3) the quadratic term [Log
(Week)]2 was the smallest using model 3. Most import-
antly, DDDYM mice attained their maximum body weight
at 16.7 weeks of age, following which their body weight
declined. Mice in the other 15 categories did not attain
their maximum body weights during the observation
period. Therefore, the lower body weight of DDDYM mice
was a consequence of body weight loss.
Diabetes mellitus is a possible cause of body weight loss
in DDD-Ay males
Diabetes and obesity are common characteristics of Ay
mice. Hyperglycemia/type 2 diabetes is a possible reason
for body weight loss in these mice. Therefore, BGLC
levels were determined to address this possibility. DDD-
Ay males showed marked hyperglycemia (Figure 3A). DB
F1-A
y males also showed hyperglycemia but did not lose
their body weight, suggesting that hyperglycemia was
not the sole cause of body weight loss. Because bodyweight loss and hyperglycemia were not observed in BD
F1-A
y males, loci homozygous for DDD alleles must have
caused the body weight loss and the maternally derived
DDD genome must have induced hyperglycemia.
We also determined plasma lipid levels because
dyslipidemia is frequently associated with diabetes and
obesity. Clearly, DDD-Ay and DDD mice had higher
plasma TG levels than B6-Ay and B6 mice for both the
sexes (Figure 3B). In particular, DDD-Ay males had sig-
nificantly higher plasma TG levels than the other strains,
except for DB F1-A
y males. In contrast, DDD-Ay and
DDD mice were not more cholesterolemic compared
with B6-Ay and B6 mice for both the sexes (Figure 3C).
Conversely, DDD-Ay males had significantly lower
plasma CHO levels than DDD and B6-Ay males.
We determined HMW adiponectin levels in parental
strains. Adiponectin is an adipokine secreted from adi-
pose tissues and is known to reverse insulin resistance
associated with obesity by stimulating glucose utilization
and fatty-acid oxidation [21,22]. Disrupting adiponectin
production and/or release causes insulin resistance and
increases serum TG levels but not serum CHO levels
[23]. Blood HMW adiponectin levels more definitively
reflect BMI, the effect of body weight loss, glucose toler-
ance, insulin sensitivity in the liver, metabolic syndrome,
and type 2 diabetes mellitus than the levels of total
adiponectin. Clearly, HMW adiponectin levels were sig-
nificantly reduced in DDD-Ay males.
We also performed histological examinations for pos-
sible abnormalities associated with body weight loss.
Liver lesions are possible associated with the advance-
ment of obesity. Unexpectedly, liver lesions were more
severe in B6-Ay mice than in DDD-Ay mice. In addition,
in our earlier observation, we detected enlarged kidneys
as a consequence of dilatation of the renal pelvis in
Figure 14 Statistical analysis with a linear model and partition method. (A) Body weights of BC Ay males at 25 weeks of age versus PGLC
levels. BC Ay males were categorized into two groups based on a partition method. The first group included nine abnormal mice and the second
group included 91 normal mice. PGLC levels were ≥715 mg/dl in abnormal mice and ≤715 mg/dl in normal mice. (B) Growth curves of
abnormal and normal BC Ay males based on model 3. Lines indicate predicted values and markers indicate observed data.
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http://www.biomedcentral.com/1471-2156/14/35DDD-Ay males; however, we failed to confirm this in a
subsequent study. Dilatation of the renal pelvis immedi-
ately suggested that the enlarged kidney could be caused
by hydronephrosis. Nakajima et al. [24] reported a high in-
cidence of hydronephrosis in DDD males, although they
did not report any evidence of body weight loss.
According to Goto et al. [25], hydronephrosis in DDD
mice is heritable and probably controlled by polygenes. Al-
though our DDD strain was a descendant of the DDD
strain used by Nakajima et al. [24] and Goto et al. [25], we
did not observe hydronephrosis in our DDD strain. Over-
all, we could not find any histological evidence that may
be associated with body weight loss in DDD-Ay males.
Based on these observations, we concluded that DDD-
Ay males suffered from diabetes mellitus.Body weight loss is heritable and controlled by a major
QTL on chromosome 4
When the agouti locus genotype was included as a co-
variate, a significant QTL × covariate interaction was
identified on chromosome 4. The importance of this
QTL was that it was significant for body weight and
BMI and it interacted with the Ay allele. That is, the ac-
tion of this QTL differed between BC non-Ay and BC Ay
males, which suggested a reason why body weight loss
occurred in DDD.Cg-Ay males but not in DDD males.
This QTL was also important because it was suggestive
QTLs for HMW adiponectin levels and BGLC and
PGLC levels. The DDD allele was associated with de-
creased body weight, BMI, and HMW adiponectin levels
and increased BGLC and PGLC levels, suggesting that
Table 9 Comparison of phenotypes between two groups
of BC Ay males clustered by the partition method






(n = 9) (n = 91)
Body weight (g) 41.2 ± 0.70c 50.17 ± 0.47
(39.59–42.83) (49.23–51.12)
BMI 3.90 ± 0.10c 4.54 ± 0.03
(3.70–4.10) (4.48–4.60)
Blood glucose (mg/dl)a 592.2 ± 4.6c 303.7 ± 13.7
(581.5–602.9) (276.6–330.8)
Plasma glucose (mg/dl) 754.8 ± 15.3c 394.9 ± 16.9
(719.6-790.0) (361.3–428.5)
Total-cholesterol (mg/dl) 133.4 ± 14.7 156.0 ± 4.6
(104.3–162.6) (146.8–165.2)
Triglyceride (mg/dl) 734.1 ± 81.7 610.9 ± 25.7
(571.9–896.3) (560.0–661.9)
HMW adiponectin (μg/ml) 2.61 ± 0.13c 3.93 ± 0.14
(2.29–2.92) (3.66–4.21)
aSeven mice had blood glucose levels that exceeded the upper limit of the
measuring method (600 mg/dl). Therefore, mean ± SE values were calculated
by assuming that their blood glucose levels were 600 mg/dl.
bPGLC indicates plasma glucose levels.
cValues are significantly different between abnormal mice and normal mice.
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http://www.biomedcentral.com/1471-2156/14/35the QTL on chromosome 4 was responsible for diabetes
mellitus. For PGLC, a larger QTL effect was identified
on chromosome 12. However, this QTL was unlikely to
be a direct cause of hyperglycemia of DDD.Cg-Ay males
because the B6 allele was associated with increased glu-
cose level at this locus. It was uncertain whether this
locus was allelic with that for TG levels because the B6
allele was associated with decreased TG levels.
The QTL on chromosome 1 contained Ifi202b and the
QTL on chromosome 4 contained Zfp69 within the 95% CI
as a strong candidate gene [19,20]. Ifi202b was identified as
a cause of Nob3, a major QTL for obesity and hypergly-
cemia in an F2 intercross between NZO and B6 mouse
strains [26]. In B6 mice, Ifi202b is disrupted by a deletion of
its 5’-flanking region including exon 1B and the promoter
[19]. According to the PCR analysis, the DDD strain had
exon 1B as opposed to B6 allele. There is no reason to ex-
clude Ifi202b as a candidate gene for the QTL on chromo-
some 1; however, we are still uncertain whether the QTL
on chromosome 1 is allelic to Nob3 because of following
reasons. First, the phenotypic effect of the QTL on chromo-
some 1 on body weight, BGLC, and PGLC was apparently
weak as compared with Nob3. Second, the B6 allele was as-
sociated with increased body weight at the present QTL,
whereas the B6 allele was associated with decreased body
weight in (NZO×B6) F2 population.On the other hand, Zfp69 was identified as a cause of
Nidd/SJL in a backcross male progeny between NZO
and SJL strains [27]. The Zfp69 gene is disrupted in B6
and NZO strains by an insertion of a retrotransposon se-
quence [20,28]. Intriguingly, disrupted allele protects
mice against diabetes. Thus, in a cross between NZO
and SJL mice, the wild-type SJL allele contributed to dia-
betes. The SJL allele at Nidd/SJL was associated with de-
creased body weight and BMI and increased BGLC and
TG levels. In the similar way as did the SJL allele at
Nidd/SJL, the DDD allele at the QTL on chromosome 4
was associated with decreased body weight and BMI and
increased BGLC, suggesting the allelism between the
two QTLs, However, our results of Zfp69 genotyping
suggested that the exon 3A was present in the DDD
strain, and that there were no differences between the
B6 and DDD alleles. In addition, we sequenced all exons
except for exon 3A in the DDD strain and found there
were no differences between the B6 and DDD alleles
(data not shown). Different from the effects associated
with Nidd/SJL, the QTL on chromosome 4 in our cross
did not have any substantial effects on TG levels. Thus,
the QTL on chromosome 4 was unlikely to be caused by
the Zfp69. However, this by no means rule out the possi-
bility that the Zfp69 plays a role in parental DDD.Cg-Ay
males because the diabetogenic effect of the Zfp69 vari-
ant is markedly dependent on interaction with other
genes of the background strain [20].
With regard to the QTL on chromosome 4, we can pos-
tulate two other candidate genes that are closely related to
body weight and diabetes mellitus. One is coristatin (Cort),
which is located at 149.13 Mbp [29]. Although the body
weight and blood glucose levels did not significantly differ
between Cort deficient (Cort−/−) and wild type (Cort+/+)
mice, Cort−/− males, but not females, showed insulin re-
sistance during insulin tolerance test. The other candidate
gene is hexose-6-phosphate dehydrogenase (H6pd), which
is located at 150 Mbp [30]. Fasting glucose level was sig-
nificantly lower in H6pd deficient (H6pd−/−) mice com-
pared with wild type (H6pd+/+) mice. At 10 weeks of age,
H6pd−/− mice were significantly lighter than H6pd+/+
mice. These are undoubtedly candidate genes for the
QTL; however, we are still uncertain whether they are
causative of the QTL because the effect of the QTL on
chromosome 4 is only apparent in the presence of the Ay
allele. That is, we cannot correctly assess their candidacy
unless these mutant phenotypes are investigated in the
presence of the Ay allele.
PGLC and HMW adiponectin levels are critical factors that
affect the body weight of BC Ay males
Our best-fit linear model included PGLC and HMW
adiponectin levels as linear or quadratic terms, which
suggested that PGLC and HMW adiponectin levels were
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as opposed to CHO and TG levels. These results were in
accordance with those of our QTL analyses.
Based on partition method analysis, nine abnormal BC
Ay males exhibited body weight loss similar to DDD-Ay
males. Furthermore, the trajectory of the growth curve
of abnormal BC Ay males was very similar to that of
DDD-Ay males. This suggested that body weight loss in
abnormal BC Ay males was caused by the same factors
that contributed to body weight loss in DDD-Ay males.
When the phenotypes were compared between the two
groups of BC Ay males, body weight, BMI, BGLC, PGLC,
and HMW adiponectin levels significantly differed be-
tween abnormal and normal mice. In contrast, CHO and
TG levels did not differ significantly between these two
groups. This suggests again that PGLC and HMW
adiponectin levels are critical factors that affect the body
weight of BC Ay males. Furthermore, the nine abnormal
BC Ay males and DDD-Ay males may have shared the
same genetic basis for body weight loss because seven of
the nine abnormal BC Ay males were homozygous for
the DDD allele at D4Mit234, a microsatellite marker
closest to the QTL on chromosome 4.
QTL on chromosome 4 as a modifier of the Ay allele
As mentioned at the beginning of the Background sec-
tion, five single gene obesity mutations are known at
present. These mutations cause obesity and diabetes in
mice. The phenotypic effects of these mutations are very
strong; nevertheless, the phenotypes caused by these
mutations are substantially influenced by the genetic
backgrounds on which these mutations are placed
[31-36]. In particular, Coleman et al. [31-33] studied the
effects of the Lepob and Leprdb mutations on B6 and
C57BL/KsJ (KSJ) backgrounds and developed the con-
cept of the diabetes-sensitive and the diabetes-resistant
backgrounds. B6 is the resistant background to diabetes
associated with obesity caused by the Lepob and Leprdb
mutations, whereas KSJ is the diabetes-sensitive back-
ground. Similarly, if we assume that DDD is the sensitive
background, B6 is again defined as the resistant back-
ground to diabetes associated with obesity caused by the
Ay allele. Therefore, the QTLs on chromosomes 1 and 4
are expected to encode genes that constitute the
diabetes-sensitive genetic background.
Conclusions
Lower body weight of DDD.Cg-Ay males was confirmed
to be a consequence of body weight loss. Although we
did not yet establish convincing evidence, diabetes
mellitus was suggested to be a possible contributing fac-
tor that caused body weight loss. Body weight loss was a
heritable phenomenon, and a QTL on distal chromo-
some 4 was suggested to be a major factor responsiblefor this. This QTL interacts with the Ay allele, suggesting
a reason why body weight loss occurs in DDD.Cg-Ay
males but not in DDD males.
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